SmithKline Beecham Biologicals S.A.
Records under this name other than patents SmithKline Beecham Biologicals S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to SmithKline Beecham Biologicals S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,192,065 | System for providing communication between the interior and the exterior of a compartment Formerly held Term ended Term ended Jun 28, 2023 · USPTO record | Term ended | Term ended Jun 28, 2023 | USPTO record |
| US 7,285,280 | Vaccine Term ended Term ended Oct 23, 2022 · USPTO record | Term ended | Term ended Oct 23, 2022 | USPTO record |
| US 8,557,251 | Non-Live Trivalent Influenza Vaccine for One-Dose Intradermal Delivery Formerly held Lapsed on the fee record Ended Oct 15, 2021 · Medium confidence | Lapsed on the fee record | Ended Oct 15, 2021 | Medium confidence |
| US 8,568,733 | HER-2/neu fusion proteins Formerly held Term ended Term ended Apr 20, 2021 · USPTO record | Term ended | Term ended Apr 20, 2021 | USPTO record |
| US 7,238,349 | Composition Term ended Term ended Jan 6, 2021 · USPTO record | Term ended | Term ended Jan 6, 2021 | USPTO record |
| US 6,780,419 | Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis Formerly held Term ended Term ended Nov 13, 2020 · USPTO record | Term ended | Term ended Nov 13, 2020 | USPTO record |
| US 6,451,320 | Combined hepatitis and herpesvirus antigen compositions Term ended Term ended Oct 27, 2020 · USPTO record | Term ended | Term ended Oct 27, 2020 | USPTO record |
| US 7,101,560 | Combination vaccine for administration to adolescents Term ended Term ended Sep 7, 2020 · USPTO record | Term ended | Term ended Sep 7, 2020 | USPTO record |
| US 7,220,551 | Composition Term ended Term ended Sep 7, 2020 · USPTO record | Term ended | Term ended Sep 7, 2020 | USPTO record |
| US 8,628,784 | Adjuvant Systems and Vaccines Formerly held Term ended Ended no later than Jun 14, 2020 · Low confidence | Term ended | Ended no later than Jun 14, 2020 | Low confidence |